Clinical Features and Outcomes of Eosinophilic Myocarditis Patients Treated with Prednisolone at a Single Institution Over a 27-Year Period
Authors:
- 1 January 2011
- journal article
- research article
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 50 (9) , 975-981
Abstract
Background Eosinophilic myocarditis is a rare clinical entity characterized by eosinophilia and myocardial inflammation with infiltrating eosinophils. The prognosis of patients with eosinophilic myocarditis is difficult to determine due the disease's rarity and varied causes; consequently, standard treatment has not been established. Objective To elucidate the clinical characteristics and treatment outcome of eosinophilic myocarditis, we retrospectively studied 7 patients fulfilling the criteria of the Japanese Circulation Society for eosinophilic myocarditis from among 64 patients admitted to our institution with eosinophilia over a 27-year period. Results The patients' ages at diagnosis ranged from 36 to 83 years (median: 52 years). The etiologies of the eosinophilic myocarditis were found to be idiopathic (3 patients), Churg-Strauss syndrome (2 patients), parasitic infection (1 patient) and chronic eosinophilic leukemia (CEL) (1 patient). In addition to treatment for the underlying disease, we also administered prednisolone at a dose appropriate to the disease severity (6 of 7 patients). The patient who was diagnosed with a parasitic infection was treated only with albendazole, because eosinophilic myocarditis was mild. The patient with CEL was positive for the FIP1 L1-PDGFRα fusion gene and was treated with imatinib. Eosinophilic cationic protein was a useful marker for assessing disease activity and treatment efficacy. At the end of the study, of the seven patients treated, six were alive (86%), giving a mean survival time of 37 ± 40 months (mean ± SD). Conclusion Because eosinophilic myocarditis has various etiologies, it is essential to identify the etiology of the underlying disease. In the majority of eosinophilic myocarditis patients, administration of prednisolone may be an effective therapeutic modality producing a good outcome.Keywords
This publication has 23 references indexed in Scilit:
- Hypereosinophilic syndrome associated with occlusive coronary thrombosis and right ventricular thrombusPathology International, 2008
- Successful imatinib treatment of cardiac involvement of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia followed by severe HepatotoxicityInternational Journal of Hematology, 2007
- Improved cardiac function in a patient with hypereosinophilic syndrome treated with imatinibEuropean Journal of Haematology, 2005
- Rapid Reversion of Loeffler's Endocarditis by Imatinib in Early Stage Clonal Hypereosinophilic SyndromeLeukemia & Lymphoma, 2004
- Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemiasLeukemia, 2004
- Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndromeBlood, 2004
- A Clinical Trial of Immunosuppressive Therapy for MyocarditisNew England Journal of Medicine, 1995
- Nonspecific myocarditis. A statistical and clinicopathological study of autopsy cases.Japanese Circulation Journal, 1989
- Steroid-responsive eosinophilic myocarditis: diagnosis by endomyocardial biopsyThe American Journal of Cardiology, 1984
- Myocarditis due to visceral larva migransThe Journal of Pediatrics, 1977